Psychological well-being and family satisfaction levels five years after being confirmed as a carrier of the Machado-Joseph disease mutation
- PMID: 23153003
- PMCID: PMC3501113
- DOI: 10.1089/gtmb.2011.0370
Psychological well-being and family satisfaction levels five years after being confirmed as a carrier of the Machado-Joseph disease mutation
Abstract
The present study on long-term outcome of presymptomatic testing for Machado-Joseph disease (MJD) aimed to evaluate the psychological well-being and the familial satisfaction of subjects that 5 years prior received an unfavorable result in the predictive testing (PT). The study included 47 testees of Azorean origin (23 from the island of Flores and 24 from S. Miguel) that completed the fourth evaluation session of the MJD protocol, and undertook a neurological examination at the moment of participation in the study. Nearly 50% of testees were symptomatic at the time of the study. Psychological well-being of the 47 participants was evaluated using the Psychological General Well-Being Index (PGWB). The family satisfaction scale by adjectives was applied to obtain information on family dynamics. The average PGWB score of the total participants was of 73.3, a value indicative of psychological well-being. Nearly half of the testees presented scores indicating psychological well-being, whereas scores indicating moderate (28.9%) or severe (23.7%) stress were found in the remaining. The average score in the PGWB scale was lower in symptomatic than in asymptomatic subjects; moreover, the distinct distribution of the well-being categories seen in the two groups shows an impact of the appearance of first symptoms on the psychological state. Motives for undertaking the test, provided 5 years prior, failed to show an impact in well-being. The average score for familial satisfaction was of 134, a value compatible with high familial satisfaction, which represented the most frequent category (59.6%). Results demonstrate that well-being and family satisfaction need to be monitored in confirmed carriers of the MJD mutation. The inclusion of acceptance studies, after PT, as well as the development of acceptance training actions, should be of major importance to anticipate the possibility of psychological damage.
Figures
Similar articles
-
Short-term psychological impact of predictive testing for Machado-Joseph disease: depression and anxiety levels in individuals at risk from the Azores (Portugal).Community Genet. 2004;7(4):196-201. doi: 10.1159/000082262. Community Genet. 2004. PMID: 15692194
-
Origins of a mutation: population genetics of Machado-Joseph disease in the Azores (Portugal).Hum Biol. 1998 Dec;70(6):1011-23. Hum Biol. 1998. PMID: 9825593
-
Disease knowledge and attitudes toward predictive testing and prenatal diagnosis in families with Machado-Joseph disease from the Azores Islands (Portugal).Community Genet. 2001;4(1):36-42. doi: 10.1159/000051154. Community Genet. 2001. PMID: 11493751
-
Psychological aspects of pre-symptomatic testing for Machado-Joseph disease and familial amyloid polyneuropathy type I.Clin Genet. 2006 Apr;69(4):297-305. doi: 10.1111/j.1399-0004.2006.00606.x. Clin Genet. 2006. PMID: 16630162 Review.
-
Origins and Spread of Machado-Joseph Disease Ancestral Mutations Events.Adv Exp Med Biol. 2018;1049:243-254. doi: 10.1007/978-3-319-71779-1_12. Adv Exp Med Biol. 2018. PMID: 29427107 Review.
Cited by
-
Choosing not to know: accounts of non-engagement with pre-symptomatic testing for Machado-Joseph disease.Eur J Hum Genet. 2019 Mar;27(3):353-359. doi: 10.1038/s41431-018-0308-y. Epub 2018 Dec 20. Eur J Hum Genet. 2019. PMID: 30573801 Free PMC article.
-
Short Communication: Restrictions in care following the COVID-19 pandemic severely impacted Machado-Joseph disease patients: a study in the Azores Islands, Portugal.J Community Genet. 2022 Aug;13(4):459-461. doi: 10.1007/s12687-022-00602-2. Epub 2022 Jul 18. J Community Genet. 2022. PMID: 35851653 Free PMC article.
-
Life paths of patients with transthyretin-related familial amyloid polyneuropathy Val30Met: a descriptive study.J Community Genet. 2018 Jan;9(1):93-99. doi: 10.1007/s12687-017-0338-0. Epub 2017 Oct 19. J Community Genet. 2018. PMID: 29052096 Free PMC article.
-
The Homogeneous Azorean Machado-Joseph Disease Cohort: Characterization and Contributions to Advances in Research.Biomedicines. 2023 Jan 18;11(2):247. doi: 10.3390/biomedicines11020247. Biomedicines. 2023. PMID: 36830784 Free PMC article. Review.
-
Genetic counseling and presymptomatic testing programs for Machado-Joseph Disease: lessons from Brazil and Portugal.Genet Mol Biol. 2014 Mar;37(1 Suppl):263-70. doi: 10.1590/s1415-47572014000200012. Genet Mol Biol. 2014. PMID: 24764760 Free PMC article.
References
-
- Bettencourt C. Santos C. Kay T, et al. Analysis of segregation patterns in Machado-Joseph disease pedigrees. J Hum Genet. 2008;53:920–923. - PubMed
-
- Coutinho P. Attempt of definition. PhD dissertation. University of Porto; Porto, Portugal: 1992. Machado-Joseph disease; p. 247.
-
- Decruyenaere M. Evers-Kiebooms G. Cloostermans T, et al. Psychological distress in the 5-year period after predictive testing for Huntington's disease. Eur J Hum Genet. 2003;11:30–38. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical